Moreover, granulocyte colony-stimulating factor (G-CSF) released by mutIDH1 glioma stem-like cells promoted myeloid cell reprogramming, which improved the efficiency of immune-stimulatory gene therapy (88) (Figure 3). Here, CSF3 is linked to glioma.